BioCryst Pharmaceuticals | BCRX - Stock





Stock Veränderung Datum
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
BioCryst Pharmaceuticals USD 6.06M 71K 2026-06
Chugai Pharma JPY 276.85B 30.52B 2025-12
Daiichi Sankyo JPY 692.38B 83.83B 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
GlaxoSmithKline GBP 6.16B 233M 2026-03
Glaxosmithkline GBP 6.16B 39M 2026-03
Incyte USD 112.54M 3.08M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Karyopharm Therapeutics USD 4.04M 72K 2025-12
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Novavax USD 10.01M 1.45M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06